Necrolytic migratory erythema

Synonyms
glucagonoma
Specialty
Dermatology · Metabolic skin disorders
Images
Clinical 4
In the app
2 flashcards
Last updated
10/2026 · Dr. Pascal Bafteh
Contents
  1. Images (4)
  2. Definition
  3. Clinical features
  4. Diagnosis
  5. Differential diagnoses
  6. Treatment principles
  7. Keep learning in the app
  8. References (selection)
  9. Cross-references

Images (4)

Necrolytic migratory erythema – clinical photo: Arm: annular erythematous plaques with accentuated, scaly and eroded borders, merging down to the hand – classic NME in glucagonoma
Arm: annular erythematous plaques with accentuated, scaly and eroded borders, merging down to the hand – classic NME in glucagonomaDidona D, Rallo A, Carugno A et al. (J Clin Med 2025), CC BY 4.0, via PubMed Central (PMC11818922) · CC BY 4.0 · Source
Necrolytic migratory erythema – clinical photo: Leg: numerous erythematous, crusted and eroded, partly confluent plaques with hyperpigmentation
Leg: numerous erythematous, crusted and eroded, partly confluent plaques with hyperpigmentationMartínez Jiménez HS (Cureus 2025), CC BY 4.0, via PubMed Central (PMC12817005) · CC BY 4.0 · Source
Necrolytic migratory erythema – abdomen, torso – clinical photo: Trunk and flank: disseminated brownish-erythematous crusted plaques with accentuated borders
Trunk and flank: disseminated brownish-erythematous crusted plaques with accentuated borders (abdomen, torso)Martínez Jiménez HS (Cureus 2025), CC BY 4.0, via PubMed Central (PMC12817005) · CC BY 4.0 · Source
Necrolytic migratory erythema – buttocks – clinical photo: well-demarcated erythematous plaques with fragile vesicles, erosions and crusts on the buttock (close-up)
well-demarcated erythematous plaques with fragile vesicles, erosions and crusts on the buttock (close-up)Sheng-li Wu, Ji-gang Bai, Jun Xu, Qing-yong Ma & Zheng Wu, “Necrolytic migratory erythema”, CC BY 4.0, via Wikimedia Commons · CC BY 4.0 · Source
1 / 4

Definition

Definition & Pathogenesis

  • Necrolytic migratory erythema (NME) = obligate paraneoplastic dermatosis of the glucagonoma (neuroendocrine pancreatic tumor, α-cell tumor), described as glucagonoma syndrome by Mallinson et al. in 1974.
  • Pathogenesis: Mechanism is hyperglucagonemia + hypoaminoacidemia + zinc/niacin/tryptophan deficiency → epidermal necrolysis with defect of keratinocyte energy supply.
  • Tumor: Causative tumor is glucagonoma (neuroendocrine α-cell pancreatic tumor; > 50 % already metastatic at diagnosis, usually liver).
  • Pseudo-glucagonoma syndrome: NME without glucagonoma in liver cirrhosis, pancreatitis, celiac disease, malabsorption (pseudo-NME) — important DD.

Clinical features

Clinical Presentation

  • Skin triad: Characteristic efflorescences are migratory, annular/circinate confluent erythemas + central bullae/erosions + marginal scaling + postinflammatory hyperpigmentation; perigenital + perianal + intertrigines + acra.
  • Mucosa: glossitis (red-smooth tongue), angular cheilitis, stomatitis.
  • System signs: Classic 4-D tetrad is Dermatitis (NME) + Diabetes mellitus + Deep vein thrombosis + Depression (+ weight loss, diarrhoea).
  • Laboratory triad: hyperglucagonemia + hypoaminoacidemia + normochromic normocytic anemia.
  • Thrombosis risk: ↑ in glucagonoma (paraneoplastic hypercoagulability).

Diagnosis

Diagnostics

  • Skin biopsy: Histological hallmark is necrolytic upper epidermal layer ("pale upper epidermis" with ballooning + confluence of necrotic keratinocytes) + parakeratosis; similar to pellagra / acrodermatitis enteropathica / necrolytic acral erythema.
  • Laboratory: Guiding lab findings are plasma glucagon ↑↑ (often many times normal) + amino acid levels ↓ + zinc/niacin often ↓ + hyperglycemia + normochromic anemia.
  • Genetics: rule out MEN-1 (multiple endocrine neoplasia type 1) in younger patients / family history.

Differential diagnoses

Image credits for the thumbnails
  • Erythema ab igne: James Heilman, MD, “Hotbottlerash”, CC BY-SA 3.0, via Wikimedia Commons · CC BY-SA 3.0 · Source
  • Psoriasis vulgaris (plaque psoriasis): MediaJet, “An Arm Covered With Plaque Type Psoriasis”, CC BY-SA 3.0, via Wikimedia Commons · CC BY-SA 3.0 · Source
  • Nummular eczema (discoid eczema): Ifnord, “Nummular dermatitits”, CC BY-SA 4.0, via Wikimedia Commons · CC BY-SA 4.0 · Source
  • Necrobiosis lipoidica: Warfieldian, “Necrobiosislipoidica”, CC BY-SA 3.0, via Wikimedia Commons · CC BY-SA 3.0 · Source
  • Pemphigus vulgaris: Mohammad2018, CC BY-SA 4.0, via Wikimedia Commons, cropped · CC BY-SA 4.0 · Source

Treatment principles

  • Treating the underlying glucagonoma is crucial; surgical tumour resection is the only curative option but is often not possible because liver metastases are frequently present at diagnosis.
  • Somatostatin analogues, which inhibit glucagon secretion, provide symptomatic relief; substitution of amino acids, trace elements and essential fatty acids often improves the skin lesions rapidly.
  • Metastatic disease is managed by the interdisciplinary tumour board; because of the increased thrombotic tendency, thromboprophylaxis should be considered.

Specific treatment regimens with drugs and doses are covered in the DermaFuchs app.

Keep learning in the app

In the DermaFuchs app you can learn Necrolytic migratory erythema with flashcards, exam questions and spot-the-diagnosis – free, in your browser or as an app.

Test yourself: Spot-diagnosis quiz with real cases →

In the app: 2 flashcards

Open in browser  Download on the App Store

References (selection)

  1. A glucagonoma syndrome
  2. The glucagonoma syndrome and necrolytic migratory erythema: a clinical review

Cross-references

Keep learning: test yourself

One question from the DermaFuchs app on Necrolytic migratory erythema – tap an answer.

Question 1 of 1

What type of pancreatic tumor is Glucagonoma?

Answer

Correct: Pancreatic α-cell tumor. Glucagonoma is a pancreatic α-cell tumor, which can cause necrolytic migratory erythema.

More questions like these – with explanations and spaced repetition – in the app.

Note: This page is intended for medical education and does not replace diagnosis or treatment decisions in individual cases.